Advantages of One Person Company: OPC Benefits Explained

About the Pharma Company in India

A pharmaceutical company is an entity involved in the development, manufacturing, distribution, and marketing of medicines and healthcare products. Depending on the business model, pharma companies in India are typically classified as:

• Manufacturing companies: involved in the production of drugs and medicines.
• Marketing companies: focus on branding and distribution, often outsourcing manufacturing.
• Wholesale businesses: supply medicines in bulk to retailers, hospitals, and distributors.
• Retail businesses: run pharmacies and directly sell medicines to consumers.

India’s pharmaceutical industry has been expanding rapidly. As of 2025, it is valued at $55 billion and is projected to reach $120–130 billion by 2030. The government has also introduced several supportive measures:

• 100% Foreign Direct Investment (FDI) allowed in greenfield pharma projects.
• ₹15,000 crore PLI (Production Linked Incentive) scheme to promote domestic manufacturing.
• Incentives for Active Pharmaceutical Ingredients (APIs) and medical devices to reduce import dependency.

With this growth potential, starting a pharmaceutical business in India is both a profitable and impactful opportunity.

Choosing the Right Business Structure for a Pharma Company

The first step in starting a pharmaceutical business in India is selecting the proper business structure. The choice depends on the scale of operations, funding requirements, and ownership preferences. Common structures include:

• Limited Liability Partnership (LLP): Offers flexibility with limited liability.
  Private Limited Company (Pvt Ltd): Ideal for manufacturing and marketing businesses due to scalability and investor appeal.
• Public Limited Company: Suitable for large-scale operations planning to raise funds from the public.
• Indian Subsidiary of a Foreign Company: Allows foreign companies to establish a presence in India and leverage the growing market.

India ranks 3rd in the world by volume and 14th by value in pharmaceuticals, making it a preferred hub for domestic and international players. Choosing the right structure ensures smooth registration and compliance.

Eligibility for Registering a Pharma Company

Eligibility criteria are designed to maintain quality and compliance in the pharma sector. Key rules include:

• The applicant must be legally competent to enter into a contract.
• The company must appoint qualified directors and pharmacists, depending on the business type.
• Proper compliance with the Drugs and Cosmetics Act of 1940 is mandatory.
• Only individuals or entities with relevant pharmaceutical qualifications/experience can run such businesses.

Requirements for Registering a Pharma Company

Corporate & Structural Requirements

These are the standard legal requirements for forming a company under the Ministry of Corporate Affairs (MCA).

• Directors and Members: The structure depends on your company type. For a Private Limited Company, a minimum of two directors and two members (shareholders) are required. The same individuals can hold both positions.
• Director Credentials: Every proposed director must have a Digital Signature Certificate (DSC) for online document submission and a Director Identification Number (DIN), a unique identifier issued by the MCA.
• Unique Company Name: Your proposed company name must be unique and not resemble any existing company or trademark. It must be approved and reserved through the MCA portal.
• Registered Office Address: You must provide a physical address in India as the company's official registered office. Proof of address, such as a utility bill or rental agreement, is mandatory for verification.

Pharmaceutical & Technical Requirements

These are specific mandates from the Drugs and Cosmetics Act, 1940, enforced by state drug control departments, which are essential for obtaining a drug license.

Qualified Technical Personnel: 

You must employ qualified individuals to supervise the sale and distribution of drugs. The requirements vary based on the business type:

• For Wholesale Business (Distribution): The operations must be supervised by a "Competent Person." This can be:
  
  • A Registered Pharmacist.
  • A graduate with at least one year of experience in dealing with drugs.
• For Retail Business (Pharmacy): All sales and dispensing activities must be conducted under the direct supervision of a Registered Pharmacist.

Adequate Storage Premises: 

You must have a proper commercial space for storing medicines. The premises are inspected by a Drug Inspector and must meet specific conditions:

• Minimum Area: Typically, a minimum of 10 square meters is required for a wholesale license. This can vary by state.
• Proper Storage Facilities: The premises must be clean, well-lit, and equipped with necessary storage solutions like cupboards, racks, and, crucially, a refrigerator and freezer to store temperature-sensitive drugs like vaccines and serums.

Enjoy limited liability protection, easy fundraising, and better brand credibility. Register your Pvt Ltd company online with Razorpay Rize and focus on building your pharmaceutical business while we handle compliance.

‍

How to Start a Pharmaceutical Company in India?

The incorporation process is now simplified through the SPICe+ (Simplified Proforma for Incorporating a Company Electronically Plus) form by the Ministry of Corporate Affairs. Steps include:

Phase 1: Business Incorporation

The first step is to register your business as a legal entity with the Ministry of Corporate Affairs (MCA). The modern SPICe+ (Simplified Proforma for Incorporating a Company Electronically Plus) form has streamlined this process significantly.

• Get Director Credentials: All proposed directors of the company must obtain a Digital Signature Certificate (DSC) and a Director Identification Number (DIN). The DSC is an electronic signature used for filing documents online, and the DIN is a unique number assigned to each director.
• Reserve a Company Name: You must apply for and reserve a unique name for your company. This can be done through the MCA portal's RUN (Reserve Unique Name) service or directly within the SPICe+ form.
• Draft Foundational Documents: Two critical documents need to be prepared:
  
  • Memorandum of Association (MoA): This document defines the company's objectives and the scope of its business activities.
  • Articles of Association (AoA): This document outlines the internal rules and regulations for managing the company.
• File the SPICe+ Form: This single, integrated web form is used to file for incorporation. It combines applications for the company name, DIN allotment, and issuance of important tax numbers like PAN and TAN.
• Receive Certificate of Incorporation: Once the MCA approves your application, you will receive a Certificate of Incorporation. This certificate includes your unique Corporate Identity Number (CIN) and officially marks the legal birth of your company.

Phase 2: Securing Pharmaceutical Licenses

This is the most critical phase and is specific to the pharmaceutical industry. These licenses are granted by the Central Drugs Standard Control Organization (CDSCO) and State Drug Control Departments.

• Drug License: This is the primary license required to deal with drugs and cosmetics. The type of license depends on your business model:
  
  • Manufacturing License: Required if you plan to manufacture drugs. This involves a rigorous inspection of your manufacturing facility to ensure it complies with Good Manufacturing Practices (GMP) and has the necessary technical staff and equipment.
  • Wholesale/Distribution License: Required for stocking, selling, and distributing drugs. This requires having adequate storage premises with proper refrigeration facilities and employing a registered pharmacist.
• GST Registration: Before you can apply for a drug license, you must complete your Goods and Services Tax (GST) registration. The GSTIN is a mandatory requirement for the drug license application.

‍

Phase 3: Brand and Tax Formalities

With your company and licenses in place, the final step is to protect your brand and manage your finances.

• Trademark Registration: It is highly advisable to register your company name, logo, and the brand names of your pharmaceutical products. This protects your intellectual property and prevents others from using similar names.
• Bank Account Opening: You can open a corporate bank account using the Certificate of Incorporation and other registration documents.

‍

Get started with Razorpay Rize and complete your company registration online in just a few clicks. Fast approvals, 100% digital process, and expert support to make your pharma business official.

Documents Required to Register a Pharma Company

Here’s a checklist of essential documents required to open pharma company:

For Indian Directors/Shareholders:

• PAN Card
• Aadhaar Card
• Passport-size photographs
• Address proof (utility bill, bank statement)

For Foreign Directors/Shareholders:

• Passport (notarised and apostilled)
• Proof of overseas address
• Photograph

For the Company:

• Registered office address proof (rent agreement/ownership proof)
• Utility bill of the premises (electricity/water bill)
• MoA and AoA

Other Registrations Required for a Pharma Company

After incorporation, a pharma company must obtain additional registrations and licenses to operate legally:

1. Drug License (under the Drugs and Cosmetics Act, 1940)
   
   
   
   • Manufacturing License
   • Wholesale License
   • Retail License
   • Loan License (for outsourcing manufacturing)
   • Import License (for foreign medicines)
     
     
2. GST Registration – Mandatory for taxation and interstate sales.
3. FSSAI Registration – Required if dealing with nutraceuticals or dietary supplements.
4. Trademark & Patent Registration – Protects brand identity and intellectual property.
5. Import Export Code (IEC) – For companies engaged in pharma exports/imports.

Frequently Asked Questions (FAQs)

What is Form 11 and How to File It? 

Form 11 is an Annual Return of LLP. Every LLP in India must file with the Registrar of Companies (RoC) under the Limited Liability Partnership Act, 2008. It serves as a comprehensive summary of the LLP's management and structure for the financial year.

Here’s what Form 11 LLP typically includes:

1. General Information:
   
   • LLP Name.
   • LLP Identification Number (LLPIN).
   • Date of Incorporation.
2. Partner Information:
   
   • Names and details of designated and other partners.
   • Changes in partnership during the financial year, such as additions, resignations, or reassignments.
3. Contribution Details:
   
   • The total contribution received by the LLP from partners.
   • Contributions made by individual partners during the year.
4. Declaration of Compliance:
   
   • A confirmation that the LLP has met its statutory obligations during the year.

Steps to File Form 11

Filing Form 11 is a straightforward process. Follow these steps to ensure compliance:

1. Download Form 11:

Visit the Ministry of Corporate Affairs (MCA) portal and download the latest version of Form 11.

2. Fill in Basic Details: 

Provide the LLP’s basic details, including:

• LLPIN.
• Date of Incorporation.
• Business activities during the financial year.

3. Enter Partner Information:
   
   • List all designated and non-designated partners.
   • Include details of any changes in partnership, such as additions or removals.
4. Attach Supporting Documents:

Upload any supporting documentation, including agreements or resolutions, if applicable.

5. Certify the Form:

Ensure the form is digitally signed by one of the designated partners using a Digital Signature Certificate (DSC).

6. Submit on MCA Portal:

Upload the completed form and pay the prescribed filing fee. Fees depend on the LLP’s total contribution as per the LLP Agreement.

Due Date for Filing Annual Return (Form 11)

The due date for filing Form 11 is May 30 every year, covering the financial year ending on March 31.

Important Note:

• Filing Form 11 is mandatory regardless of whether the LLP has started its business. Even dormant LLPs are required to submit their annual return.

If you don’t file before Form 11 LLP’s due date, you can be penalised, so it's crucial to adhere to the timeline.

Additional Fee (Penalty) for Belated Filing of Annual Return (Form 11)

Failure to file Form 11 on or before May 30 can lead to significant financial penalties and legal complications. 

• A penalty of LLP form 11 late fee of ₹100 per day is imposed for each day the filing is delayed.
• The penalty has no upper limit, which means prolonged delays can result in substantial fines.

Continued non-compliance may lead to the LLP being marked as inactive by the RoC. While the designated partners may face disqualification from holding similar roles in other companies or LLPs.

What Are The Prerequisites?

Before filing, ensure that you’re fulfilling certain Form 11 LLp requirements:

1. The LLP is registered and has an active status on the MCA portal.
2. A valid DPIN of the Partner.
3. A Digital Signature Certificate (DSC) is available for at least one designated partner.
4. All pending compliance forms, such as Form 3 (LLP Agreement), have been filed.

What Are the Documents to be Submitted Along with Form 11?

Depending on the changes or updates during the year, the following documents are required for Form 11 LLP submission:

1. List of Partners:

A detailed list of designated and other partners, including their roles and contributions.

2. Contribution Proof:

Evidence of the capital contributed by each partner during the financial year.

3. Supporting Agreements:

Copies of resolutions or amendments to the LLP Agreement, if applicable.

4. Additional Documents:

Any other documents as required by the MCA portal based on the LLP’s activities.

{{llp-cta}}

Important Aspects to Note While Filing Annual Return for LLP

While LLP annual filling might seem straightforward, there are key details and considerations that can make a big difference. Overlooking these aspects could lead to errors, delays, or unnecessary penalties. To help you navigate this process smoothly, here are some important points to remember while filing your LLP’s annual return.

1. Accuracy of Partner Details:

Ensure the names, roles, and contributions of all partners are correctly listed, as discrepancies can lead to rejections or penalties.

2. Difference Between Forms:

Do not confuse Form 11 for LLP with Form 8, which deals with the financial health and solvency of the LLP. Both must be filed annually.

3. Digital Signature Validity:

Verify the validity of the Digital Signature Certificate (DSC) before submission to avoid technical issues.

Certification in Annual Return (Form 11)

Certification plays a crucial role in the filing of Form 11 (Annual Return) for an LLP. It ensures that the information provided is accurate and compliant with the statutory requirements. 

While the form can be filed by the designated partner(s), certain conditions require additional certification by a practising professional, such as a Company Secretary.

When is Certification Required?

For LLPs meeting certain financial thresholds, certification of Form 11 by a professional ( Company Secretary) is mandatory:

• If the LLP’s contribution exceeds ₹50 lakhs, or
• If its turnover exceeds ₹5 crores,

Frequently Asked Questions

Lack of a Clear Value Proposition

A strong value proposition is the foundation of any successful fundraising pitch. Yet, many founders struggle to explain what truly sets their startup apart. VCs in India often report that over 60% of the pitches they reject fail at this first hurdle. Investors aren't just backing ideas—they're investing in solutions that address real market needs with a clear, defensible growth path.

The Impact:

• A weak or generic value proposition makes it hard for investors to see the potential for a 10x-100x return on investment.
• It raises doubts about the founder’s understanding of the market. An average investor spends less than three minutes reviewing a pitch deck; a confusing message means instant rejection.

How to Avoid It:

• Articulate your Problem-Solution Fit: Quantify the problem. Instead of "we help SMEs digitize," say "we help India's 63 million SMEs reduce their average monthly accounting overhead by 30%."
• Highlight Unique Differentiators: Is it your proprietary tech, an exclusive partnership, a revolutionary business model (e.g., unique GTM strategy for Tier-2/3 cities), or a founding team with deep domain expertise from a relevant unicorn?
• Keep it Concise: Practice a 30-second elevator pitch that clearly states the problem, solution, target market, and secret sauce.

Underestimating Market Size and Competition

Many founders present overly optimistic market size estimates, often citing a massive, irrelevant TAM. Investors quickly pick up on these gaps, which signal poor research and a weak business strategy.

The Impact:

• Claiming the entire $150 billion Indian retail market for a niche D2C fashion brand erodes credibility instantly.
• Ignoring direct and indirect competitors shows a lack of preparedness. An investor will likely know the competitive landscape better than you.

How to Avoid It:

• Use Credible Data: Back your market estimates with data from sources like NASSCOM, Bain & Company, Inc42, Tracxn, or government reports (e.g., Economic Survey of India).
• Present a Clear TAM, SAM, SOM:
  
  • Total Addressable Market (TAM): The total market demand (e.g., The entire Indian EdTech market, valued at $29 billion by 2030).
  • Serviceable Available Market (SAM): The segment you can target (e.g., K-12 test prep market in India, estimated at $10 billion).
  • Serviceable Obtainable Market (SOM): What you can realistically capture in 3-5 years (e.g., 1-2% of the SAM, representing a $100-$200 million revenue opportunity).
• Showcase Competitive Analysis: Create a competitive matrix that maps key players against features, pricing, and market share. Clearly articulate your unique edge.

Insufficient Due Diligence on Investors

In the rush to secure funding, many startups forget that an investor-founder relationship is a long-term partnership, often lasting 7-10 years. Not every investor is the right fit for your business.

The Impact:

• Misaligned goals can lead to conflict. An investor seeking a quick 2-year exit will clash with a founder building for long-term market leadership.
• Some investors carry reputational risks or have a portfolio full of conflicting companies, which can harm your business.

How to Avoid It:

• Research Investor Portfolios: Use platforms like Tracxn or Crunchbase to see their past investments, sector focus, typical cheque size, and involvement level.
• Conduct "Reverse Due Diligence": Talk to at least 2-3 founders from their portfolio. Ask about their experience, the value-add beyond capital, and how the investor behaves during challenging times.
• Ensure Vision Alignment: Discuss your long-term vision, potential exit scenarios, and governance expectations before signing the term sheet.

‍

Poor Financial Projections

Financial projections aren’t just numbers on a slide—they're a reflection of your business acumen. Investors expect thoughtful, data-driven projections that are realistic and achievable.

The Impact:

• Projecting 100% month-on-month growth for 36 months without validated unit economics (CAC, LTV) is a major red flag.
• Unrealistic forecasts that show profitability in six months for a deep-tech R&D startup diminish trust in your planning abilities.

How to Avoid It:

• Build Bottom-Up Projections: Base your forecasts on key drivers: marketing spend, conversion rates, sales team efficiency, production capacity, and churn rates.
• Show Key Metrics: Clearly state your assumptions for Customer Acquisition Cost (CAC), Lifetime Value (LTV), Churn Rate, and Monthly Burn Rate. A healthy LTV/CAC ratio (ideally >3:1) is a strong positive signal.
• Present Scenarios: Show a baseline (most likely), an optimistic, and a conservative case. This demonstrates strategic thinking.

‍

Ignoring Legal and Regulatory Compliance

This is one of the most critical and overlooked areas. Non-compliance with Indian regulations can kill a deal during due diligence.

The Impact:

• Legal and compliance issues are a leading cause for fundraising delays, with 25-30% of deals facing hurdles at the due diligence stage due to poor documentation.
• Non-compliance with the Companies Act, 2013, or FDI norms can lead to hefty penalties, voiding of share allotment, or even criminal proceedings.

How to Avoid It:

• Maintain a "Virtual Data Room" (VDR): Keep all documents audit-ready. This includes:
  
  • Corporate Documents: Certificate of Incorporation, Memorandum of Association (MoA), Articles of Association (AoA).
  • Secretarial Records: Up-to-date statutory registers, board minutes, and shareholder resolutions.
  • Cap Table: A clean, accurate capitalization table. Any discrepancy here is a major red flag.
  • IP: All intellectual property assignments from founders, employees, and consultants are properly documented.
  • Employee Documentation: Compliant employment agreements and a properly structured and approved Employee Stock Option Plan (ESOP).
• Comply with FDI Regulations: If raising from foreign investors, ensure compliance with FEMA (Foreign Exchange Management Act) regulations, including sectoral caps, pricing guidelines, and timely reporting to the RBI through the FIRMS portal (Form FC-GPR must be filed within 30 days of share allotment).
• Engage Professionals: Work with a qualified Company Secretary (CS) and a corporate lawyer from day one. The cost is negligible compared to the cost of a failed funding round.

‍

Overvaluing Your Startup

An inflated valuation without the backing of strong metrics can scare off investors. The Indian market has seen valuation corrections, with late-stage valuations dropping by 20-25% in 2023.

The Impact:

• A high valuation sets unrealistic expectations, making future rounds difficult and increasing the risk of a "down round," which demoralizes employees and signals distress to the market.
• For a pre-revenue idea, asking for a ₹50 Crore ($6 million) valuation will likely get you laughed out of the room. A typical Indian idea-stage valuation is in the ₹5-15 Crore ($0.6M - $1.8M) range.

How to Avoid It:

• Benchmark Your Valuation: Research recent deals in your sector and stage in India. A seed-stage SaaS startup with ₹1 Crore ($120k) in ARR might command a valuation between ₹10-20 Crore (10x-20x ARR), not ₹100 Crore.
• Focus on Building Value: Traction speaks louder than projections. Show month-on-month growth in users, revenue, or engagement before demanding a premium valuation.
• Be Negotiable: Use convertible instruments like iSAFE notes (India Simple Agreement for Future Equity) to defer the valuation discussion to a later, metrics-backed round.

‍

Focusing Solely on Equity Funding

Equity isn't the only option. India's venture debt market has grown significantly, with over $1.2 billion disbursed in 2023. Overlooking alternatives can lead to unnecessary dilution.

The Impact:

• Selling 20-25% of your company at the seed stage can lead to founders having less than 50% ownership by Series A, reducing their control and motivation.
• You may be missing out on non-dilutive capital that is better suited for your needs (e.g., funding inventory).

How to Avoid It:

• Explore Venture Debt: If you have predictable revenue streams, venture debt can fund working capital or marketing expenses with minimal dilution (1-2% warrant coverage vs. 20% equity).
• Look into Grants and Government Schemes: Investigate programs like the Startup India Seed Fund Scheme (SISFS), SIDBI Fund of Funds, and various state-level grants that provide capital without taking equity.
• Consider Revenue-Based Financing: For businesses with recurring revenue (SaaS, D2C subscriptions), platforms offer capital in exchange for a percentage of future revenue, with no equity dilution.

Rushing the Fundraising Process

Fundraising is a marathon, not a sprint. The pressure to secure capital often leads to a rushed process, resulting in bad deals or missed opportunities.

The Impact:

• A rushed pitch appears unprofessional and unprepared. Investors can sense desperation.
• Founders often accept the first term sheet they receive, which may have predatory clauses (e.g., aggressive liquidation preferences, broad veto rights).

How to Avoid It:

• Plan for a 4-6 Month Cycle: The average fundraising process in India, from the first outreach to money in the bank, takes 4-6 months. Start well before your cash runs out.
• Prepare a Target List: Research and build a list of 50-100 relevant investors. Fundraising is a numbers game. You might need 100+ conversations to get 1-2 term sheets.

Build Relationships Early: Don't reach out to investors only when you need money. Connect with them on LinkedIn, share updates, and seek advice months in advance. A warm introduction from a trusted source increases your chance of getting a meeting by over 10x.